The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Review: Role of developmental inflammation and blood–brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases
Open accessAbstract
The causes of most neurological disorders are not fully understood. Inflammation and blood–brain barrier dysfunction appear to play major roles in the pathology of these diseases. Inflammatory insults that occur during brain development may have widespread effects later in life for a spectrum of neurological disorders. In this review, a new hypothesis suggesting a mechanistic link between inflammation and blood–brain barrier function (integrity), which is universally important in both neurodevelopmental and neurodegerative diseases, is proposed. The role of inflammation and the blood–brain barrier will be discussed in cerebral palsy, schizophrenia, Parkinson's disease, Alzheimer's disease and multiple sclerosis, conditions where both inflammation and blood–brain barrier dysfunction occur either during initiation and/or progression of the disease. We suggest that breakdown of normal blood–brain barrier function resulting in a short‐lasting influx of blood‐born molecules, in particular plasma proteins, may cause local damage, such as reduction of brain white matter observed in some newborn babies, but may also be the mechanism behind some neurodegenerative diseases related to underlying brain damage and long‐term changes in barrier properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149
Back, S. A., Luo, N. L., Borenstein, N. S., Levine, J. M., Volpe, J. J., & Kinney, H. C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01302.2001 · Cited by 937
Maternal Intrauterine Infection, Cytokines, and Brain Damage in the Preterm Newborn
Dammann, O., & Leviton, A. (1997) · Pediatric Research · doi:10.1203/00006450-199707000-00001 · Cited by 893
Selective Vulnerability of Late Oligodendrocyte Progenitors to Hypoxia–Ischemia
Back, S. A., Han, B. H., Luo, N. L., Chricton, C. A., Xanthoudakis, S., Tam, J., Arvin, K. L., & Holtzman, D. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00455.2002 · Cited by 795
Yoon, B. H., Romero, R., Park, J. S., Kim, C. J., Kim, S. H., Choi, J.-H., & Han, T. R. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.104207 · Cited by 779
The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
Hauser, S. L., & Oksenberg, J. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.011 · Cited by 776
Neurovascular mechanisms of Alzheimer's neurodegeneration
Zlokovic, B. V. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.02.001 · Cited by 770
Blood–brain barrier dysfunction in parkinsonian midbrain in vivo
Kortekaas, R., Leenders, K. L., van Oostrom, J. C. H., Vaalburg, W., Bart, J., Willemsen, A. T. M., & Hendrikse, N. H. (2005) · Annals of Neurology · doi:10.1002/ana.20369 · Cited by 733
The influence of cytokines on the integrity of the blood-brain barrier in vitro
de Vries, H. E., Blom-Roosemalen, M. C. M., Oosten, M. V., de Boer, A. G., van Berkel, T. J. C., Breimer, D. D., & Kuiper, J. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00148-4 · Cited by 665
Regulation of tight junctions and loss of barrier function in pathophysiology
Harhaj, N. S., & Antonetti, D. A. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.08.007 · Cited by 545
Pardo, C. A., & Eberhart, C. G. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00102.x · Cited by 514
Microvascular injury and blood–brain barrier leakage in Alzheimer's disease
Zipser, B. D., Johanson, C. E., Gonzalez, L., Berzin, T. M., Tavares, R., Hulette, C. M., Vitek, M. P., Hovanesian, V., & Stopa, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.016 · Cited by 487
Inflammatory cytokines in the pathogenesis of periventricular leukomalacia
Kadhim, H., Tabarki, B., Verellen, G., De Prez, C., Rona, A.-M., & Sébire, G. (2001) · Neurology · doi:10.1212/wnl.56.10.1278 · Cited by 396
Kirk, J., Plumb, J., Mirakhur, M., & McQuaid, S. (2003) · The Journal of Pathology · doi:10.1002/path.1434 · Cited by 375
Saukkonen, K., Sande, S., Cioffe, C., Wolpe, S., Sherry, B., Cerami, A., & Tuomanen, E. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.2.439 · Cited by 361
Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease Model
UJIIE, M., DICKSTEIN, D. L., CARLOW, D. A., & JEFFERIES, W. A. (2003) · Microcirculation · doi:10.1038/sj.mn.7800212 · Cited by 351
Engelhardt, B., & Wolburg, H. (2004) · European Journal of Immunology · doi:10.1002/eji.200425327 · Cited by 334
Werring, D. J. (2000) · Brain · doi:10.1093/brain/123.8.1667 · Cited by 326
Blood–brain barrier impairment in Alzheimer disease: Stability and functional significance
Bowman, G. L., Kaye, J. A., Moore, M., Waichunas, D., Carlson, N. E., & Quinn, J. F. (2007) · Neurology · doi:10.1212/01.wnl.0000262031.18018.1a · Cited by 293
Floris, S., Blezer, E. L. A., Schreibelt, G., Döpp, E., van der Pol, S. M. A., Schadee‐Eestermans, I. L., Nicolay, K., Dijkstra, C. D., & de Vries, H. E. (2004) · Brain · doi:10.1093/brain/awh068 · Cited by 272
Lossinsky, A. S., & Shivers, R. R. (2004) · PubMed · doi:10.14670/hh-19.535 · Cited by 272
Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression
Huber, J. D., Witt, K. A., Hom, S., Egleton, R. D., Mark, K. S., & Davis, T. P. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.3.h1241 · Cited by 266
Fatemi, S. H., Earle, J., Kanodia, R., Kist, D., Emamian, E. S., Patterson, P. H., Shi, L., & Sidwell, R. (2002) · Cellular and Molecular Neurobiology · doi:10.1023/a:1015337611258 · Cited by 261
THE TIGHT JUNCTION: Morphology to Molecules
Stevenson, B. R., & Keon, B. H. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.89 · Cited by 256
Anthony, D. (1997) · Brain · doi:10.1093/brain/120.3.435 · Cited by 252
Pang, Y., Cai, Z., & Rhodes, P. G. (2003) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00606-5 · Cited by 248
Ling, Z., Gayle, D. A., Ma, S. Y., Lipton, J. W., Tong, C. W., Hong, J., & Carvey, P. M. (2002) · Movement Disorders · doi:10.1002/mds.10078 · Cited by 241
Inflammatory Cell Migration into the Central Nervous System: A Few New Twists on an Old Tale
Man, S., Ubogu, E. E., & Ransohoff, R. M. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00067.x · Cited by 235
Barriers in the brain: a renaissance?
Saunders, N. R., Ek, C. J., Habgood, M. D., & Dziegielewska, K. M. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.03.003 · Cited by 228
Self-citationWolburg, H., Wolburg-Buchholz, K., & Engelhardt, B. (2005) · Acta Neuropathologica · doi:10.1007/s00401-004-0928-x · Cited by 225
Wuerfel, J. (2004) · Brain · doi:10.1093/brain/awh007 · Cited by 225
Blood vessels change in the mesencephalon of patients with Parkinson's disease
Faucheux, B. A., Agid, Y., Hirsch, E. C., & Bonnet, A.-M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00641-8 · Cited by 218
Blamire, A. M., Anthony, D. C., Rajagopalan, B., Sibson, N. R., Perry, V. H., & Styles, P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-21-08153.2000 · Cited by 210
Tomás-Camardiel, M., Rite, I., Herrera, A. J., de Pablos, R. M., Cano, J., Machado, A., & Venero, J. L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.010 · Cited by 203
Cullen, K. M., Kócsi, Z., & Stone, J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.016 · Cited by 197
TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice
Zhao, C., Ling, Z., Newman, M. B., Bhatia, A., & Carvey, P. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.012 · Cited by 183
Dousset, V., Brochet, B., Deloire, M. S. A., Lagoarde, L., Barroso, B., Caillé, J. M., & Petry, K. G. (2006) · PubMed · Cited by 183
Nelson, K. B., & Grether, J. K. (1999) · Current Opinion in Pediatrics · doi:10.1097/00008480-199912000-00002 · Cited by 182
Rousset, C. I., Chalon, S., Cantagrel, S., Bodard, S., Andres, C., Gressens, P., & Saliba, E. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000199905.08848.55 · Cited by 181
Nawa, H., & Takei, N. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.06.002 · Cited by 174
Marco, S., & Skaper, S. D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.047 · Cited by 172
Lindberg, R. L. P. (2001) · Brain · doi:10.1093/brain/124.9.1743 · Cited by 166
Immunolocalization of tight junction proteins in the adult and developing human brain
Virgintino, D., Errede, M., Robertson, D. M., Capobianco, C., Girolamo, F., Vimercati, A., Bertossi, M., & Roncali, L. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0665-1 · Cited by 165
The blood–CSF barrier explained: when development is not immaturity
Johansson, P. A., Dziegielewska, K. M., Liddelow, S. A., & Saunders, N. R. (2008) · BioEssays · doi:10.1002/bies.20718 · Cited by 160
Self-citationStolp, H. B., Dzięgielewska, K. M., Ek, C. J., Potter, A., & Saunders, N. R. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04483.x · Cited by 159
Self-citationPathogenesis of multiple sclerosis
Prat, A., & Antel, J. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000169737.99040.31 · Cited by 158
Clifford, P. M., Zarrabi, S., Siu, G., Kinsler, K., Kosciuk, M. C., Venkataraman, V., D’Andrea, M. R., Dinsmore, S. T., & Nagele, R. G. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.070 · Cited by 152
Ek, C. J., Dzięgielewska, K. M., Stolp, H. B., & Saunders, N. R. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20885 · Cited by 150
Self-citationA morphometric study of the blood-brain barrier in Alzheimer's disease.
Stewart, P. A., Hayakawa, K., Akers, M.-A., & Vinters, H. V. (1992) · PubMed · Cited by 148
Blood–brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons
Rite, I., Machado, A., Cano, J., & Venero, J. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04567.x · Cited by 147
Leech, S., Kirk, J., Plumb, J., & McQuaid, S. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00781.x · Cited by 137
Pericapillary Haem-Rich Deposits: Evidence for Microhaemorrhages in Aging Human Cerebral Cortex
Cullen, K. M., Kócsi, Z., & Stone, J. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600155 · Cited by 137
A Review of Blood–Brain Barrier Transport Techniques
Smith, Q. R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-419-0:193 · Cited by 135
Systemic cytokine administration can affect blood-brain barrier permeability in the rat
Saija, A., Princi, P., Lanza, M., Scalese, M., Aramnejad, E., & Sarro, A. D. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00008-t · Cited by 132
Veldhuis, W. B., Floris, S., van der Meide, P. H., Vos, C. M. P., de Vries, H. E., Dijkstra, C. D., Bär, P. R., & Nicolay, K. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000080701.47016.24 · Cited by 127
Perinatal telencephalic leucoencephalopathy.
Gilles, F. H., & Murphy, S. F. (1969) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.32.5.404 · Cited by 120
Morgan, L., Shah, B., Rivers, L. E., Barden, L., Groom, A. J., Chung, R., Higazi, D., Desmond, H., Smith, T., & Staddon, J. M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.04.051 · Cited by 118
Ling, Z. D., Chang, Q., Lipton, J. W., Tong, C. W., Landers, T. M., & Carvey, P. M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.12.017 · Cited by 115
Stolp, H. B., Dzięgielewska, K. M., Ek, C. J., Habgood, M. D., Lane, M. A., Potter, A., & Saunders, N. R. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-1088-6 · Cited by 114
Self-citationAdd Alzheimer's disease to the list of autoimmune diseases
D’Andrea, M. R. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.08.024 · Cited by 113
Aβ peptide immunization restores blood‐brain barrier integrity in Alzheimer disease
Dickstein, D. L., Biron, K. E., Ujiie, M., Pfeifer, C. G., Jeffries, A. R., & Jefferies, W. A. (2006) · The FASEB Journal · doi:10.1096/fj.05-3956com · Cited by 111
Veszelka, S., Pásztói, M., Farkas, A. E., Krizbai, I. A., Dung, N. T. K., Niwa, M., Ábrahám, C. S., & Deli, M. A. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.08.006 · Cited by 110
Xu, F., Grande, A., Robinson, J. K., Previti, M. L., Vasek, M. J., Davis, J., & Nostrand, W. E. V. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.01.043 · Cited by 104
Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease
Quinn, J. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00037-7 · Cited by 102
Ek, C. J., Habgood, M. D., Dzięgielewska, K. M., & Saunders, N. R. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10661 · Cited by 100
Fabis, M. J., Scott, G. S., Kean, R. B., Koprowski, H., & Hooper, D. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701252104 · Cited by 99
Receptor-Mediated Transport of Human Amyloid β-Protein 1–40 and 1–42 at the Blood–Brain Barrier
Poduslo, J. F., Curran, G. L., Sanyal, B., & Selkoe, D. J. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0238 · Cited by 94
Ábrahám, C. S., Deli, M. A., Joo, F., Megyeri, P., & Torpier, G. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12546-5 · Cited by 89
Wong, D., Prameya, R., & Dorovini-Zis, K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.12.003 · Cited by 88
Effect of endotoxin on permeability of bovine cerebral endothelial cell layers in vitro.
de Vries, H. E., Blom-Roosemalen, M. C. M., Boer, A. G. D., van Berkel, T. J. C., Breimer, D. D., & Kuiper, J. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13090-5 · Cited by 84
Cerebrovascular Responses in the Fetal Sheep Brain to Low-Dose Endotoxin
Yan, E. B., Castillo-Meléndez, M., Nicholls, T., Hirst, J. J., & Walker, D. W. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000115681.95957.d4 · Cited by 84
INVESTIGATING THE NEURODEVELOPMENTAL HYPOTHESIS OF SCHIZOPHRENIA
Rehn, A., & Rees, S. M. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04257.x · Cited by 81
White matter abnormalities in autism detected through transverse relaxation time imaging
Hendry, J., DeVito, T. J., Gelman, N., Densmore, M., Rajakumar, N., Pavlosky, W. F., Williamson, P., Thompson, P. M., Drost, D. J., & Nicolson, R. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.08.039 · Cited by 80
Kim, K. S., Wass, C. A., & Cross, A. S. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6458 · Cited by 80
Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion.
Ellison, M. D., Povlishock, J. T., & Merchant, R. E. (1987) · PubMed · Cited by 74
Introduction to the Blood-Brain Barrier: Methodology, Biology and Pathology
MNH (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199904000-00012 · Cited by 73
ller, N. M. ⁄., Riedel, M. J., Hadjamu, M., Schwarz, M., Ackenheil, M., & Gruber, R. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.634 · Cited by 72
Miao, J., Vitek, M. P., Xu, F., Previti, M. L., Davis, J., & Nostrand, W. E. V. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1306-05.2005 · Cited by 69
Ek, C. J., Habgood, M. D., Dzięgielewska, K. M., Potter, A., & Saunders, N. R. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00841.x · Cited by 69
Abnormal cerebrospinal fluid protein indices in schizophrenia
Kirch, D. G., Kaufmann, C. A., Papadopoulos, N. M., Martin, B., & Weinberger, D. R. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90002-2 · Cited by 67
Kandimalla, K. K., Curran, G. L., Holasek, S. S., Gilles, E. J., Wengenack, T. M., & Poduslo, J. F. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.081901 · Cited by 63
Muller, D., Pender, M. P., & Greer, J. M. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.11.011 · Cited by 60
Rosenberg, G. A., Estrada, E. Y., & Mobashery, S. (2006) · Brain Research · doi:10.1016/j.brainres.2006.11.041 · Cited by 59
Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia
Kirch, D. G., Alexander, R., Suddath, R. L., Papadopoulos, N. M., Kaufmann, C. A., Daniel, D. G., & Wyatt, R. J. (1992) · Journal of Neural Transmission · doi:10.1007/bf01250674 · Cited by 53
Blood—brain barrier breakdown in MBP-specific T cell induced experimental allergic encephalomyelitis
Namer, I. J., Steibel, J., Poulet, P., Armspach, J., Mohr, M., Mauss, Y., & Chambron, J. (1993) · Brain · doi:10.1093/brain/116.1.147 · Cited by 46
Wagner, K. R., Dean, C., Beiler, S. L., Bryan, D., Packard, B. D., Smulian, A. G., Linke, M. J., & de Courten‐Myers, G. M. (2005) · Current Neurovascular Research · doi:10.2174/1567202053586785 · Cited by 46
Inflammation takes on Alzheimer disease
Golde, T. E. (2002) · Nature Medicine · doi:10.1038/nm0902-936 · Cited by 45
Multiple Sclerosis - A Coordinated Immune Attack Across the Blood Brain Barrier
Hemmer, B., Cepok, S., Zhou, D., & Sommer, N. (2004) · Current Neurovascular Research · doi:10.2174/1567202043480152 · Cited by 45
Matsumoto, Y., Yanase, D., Noguchi‐Shinohara, M., Ono, K., Yoshita, M., & Yamada, M. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000100019 · Cited by 43
Macromolecules involved in production and metabolism of beta-amyl oid at the brain barriers
Crossgrove, J. S., Smith, E. L., & Zheng, W. (2007) · Brain Research · doi:10.1016/j.brainres.2006.12.022 · Cited by 42
Shukla, A., Dikshit, M., & Srimal, R. C. (1995) · Neuroreport · doi:10.1097/00001756-199508000-00010 · Cited by 42
Integrity of the blood–cerebrospinal fluid barrier in early Parkinson's disease
Häussermann, P., Kuhn, W., Przuntek, H., & Müller, T. H. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01574-9 · Cited by 42
Bickel, U., Grave, B., Kang, Y., del Rey, A., & Voigt, K. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00004-6 · Cited by 41
Stolp, H. B., Ek, C. J., Johansson, P. A., Dzięgielewska, K. M., Potter, A., Habgood, M. D., & Saunders, N. R. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05973.x · Cited by 40
Self-citationImmunolocalization of tight junction proteins in blood vessels in human germinal matrix and cortex
Anstrom, J. A., Thore, C. R., Moody, D. M., & Brown, W. R. (2006) · Histochemistry and Cell Biology · doi:10.1007/s00418-006-0232-z · Cited by 31
(2003) · Nature Neuroscience · doi:10.1038/nn0403-323 · Cited by 7
(1990) · PubMed Central
Cited by
Maternal immune activation and abnormal brain development across CNS disorders
Knuesel, I., Chicha, L., Britschgi, M., Schobel, S. A., Bodmer, M., Hellings, J. A., Toovey, S., & Prinssen, E. P. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.187 · Cited by 880
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
Barrier Mechanisms in the Developing Brain
Saunders, N. R., Liddelow, S. A., & Dziegielewska, K. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00046 · Cited by 502
Self-citationMo, C., Wang, L., Zhang, J., Numazawa, S., Tang, H., Tang, X., Han, X., Li, J., Yang, M., Wang, Z., et al. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5116 · Cited by 443
González, H., Elgueta, D., Montoya, A., & Pacheco, R. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.07.012 · Cited by 352
Metadata
- Authors
- Stolp, H. B., & Dziegielewska, K. M.
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2009-03-05
- Volume
- 35
- Issue
- 2
- Pages
- 132-146
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- OpenAlex
- W2033810903
- Cited by
- 257
- References
- 97
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.